Patrick Y Muller

Processing of gene expression data generated by quantitative real-time RT-PCR.

Zuzana Dobbie, Patrick Y Muller, Harald Janovjak, 2002, BioTechniques.

Comparative quantification of pharmacodynamic parameters of chiral compounds (RRR- vs. all-rac-alpha tocopherol) by global gene expression profiling.

Jan Frank, Patrick Y Muller, Gerald Rimbach, 2005, Journal of plant physiology.

The minimum anticipated biological effect level (MABEL) for selection of first human dose in clinical trials with monoclonal antibodies.

Peter Lloyd, Jennifer Sims, Patrick Y Muller, 2009, Current opinion in biotechnology.

Comparative requirements for exploratory clinical trials -- eIND, eCTA and microdosing.

Patrick Y Muller, P. Y. Muller, 2011, Advanced drug delivery reviews.

Tissue-specific, non-invasive toxicity biomarkers: translation from preclinical safety assessment to clinical safety monitoring

Frank Dieterle, Patrick Y Muller, F. Dieterle, 2009, Expert opinion on drug metabolism & toxicology.